Health-related quality of life in gout: a systematic review

…, E Roddy, L Clarson, J Richardson, SL Hider… - …, 2013 - academic.oup.com
Objectives. To identify the instruments that have been used to measure health-related quality
of life (HRQOL) in gout and assess their clinimetric properties, determine the distribution of …

Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis

LE Clarson, P Chandratre, SL Hider… - European journal of …, 2015 - academic.oup.com
Background Hyperuricaemia, the biochemical precursor to gout, has been shown to be an
independent risk factor for mortality from cardiovascular disease (CVD), although studies …

Thromboembolism with Janus kinase (JAK) inhibitors for rheumatoid arthritis: how real is the risk?

IC Scott, SL Hider, DL Scott - Drug safety, 2018 - Springer
… Samantha Hider has no conflicts of interest that are directly relevant to the content of this
study. Professor David L. Scott has received fees for consulting and giving educational lectures …

Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A

…, S Eyre, PD Gilbert, SL Hider, AM Hinks, SL John… - Nature, 2007 - nature.com
The major histocompatibility complex (MHC) on chromosome 6 is associated with susceptibility
to more common diseases than any other region of the human genome, including almost …

Depression in RA patients treated with anti-TNF is common and under-recognized in the rheumatology clinic

SL Hider, W Tanveer, A Brownfield, DL Mattey… - …, 2009 - academic.oup.com
Objectives. Depression is common in RA and may be influenced by both disease activity
and severity. The aims of this study were to investigate the prevalence of depression in RA …

Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients

SA Owen, SL Hider, P Martin, IN Bruce… - The …, 2013 - nature.com
We investigated the effect of single-nucleotide polymorphisms (SNPs) spanning 10
methotrexate (MTX) pathway genes, namely AMPD1, ATIC, DHFR, FPGS, GGH, ITPA, MTHFD1, …

Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink

LE Clarson, SL Hider, J Belcher, C Heneghan… - Annals of the …, 2015 - ard.bmj.com
Objectives To determine whether gout increases risk of incident coronary heart disease (CHD),
cerebrovascular (CVD) and peripheral vascular disease (PVD) in a large cohort of …

The impact of low back-related leg pain on outcomes as compared with low back pain alone: a systematic review of the literature

K Konstantinou, SL Hider, JL Jordan… - The Clinical journal …, 2013 - journals.lww.com
Objectives: Low back pain (LBP) with leg pain, especially with findings of nerve root
involvement, is considered as a poor prognostic indicator although it seems to have a favorable …

The pharmacogenetics of methotrexate

SL Hider, IN Bruce, W Thomson - Rheumatology, 2007 - academic.oup.com
Methotrexate (MTX) is a cornerstone of therapy for rheumatoid arthritis. However, it is not
universally effective and up to one-third of patients fail to respond to treatment, either because …

MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T …

SA Owen, M Lunt, J Bowes, SL Hider… - The …, 2013 - nature.com
Association of two key variants mapping to the MTHFR gene (C677T (rs1801133) and
A1298C (rs1801131)) with response to methotrexate (MTX) remains controversial. We …